TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
TCL Archive Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies June 25, 2010
TCL Archive Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations August 31, 2001
TCL Archive ACS to Being Review Of Facilities Survey Proposals; Working Group Established May 25, 1984
